Notice of Intent to Limit Sources - Business Data Enrichment Services

SOL #: FDA-NOI-75F40125Q00020Special NoticeSole Source

Overview

Buyer

Health And Human Services
Washington, DC, 20201, United States

Place of Performance

MD

NAICS

Other Computer Related Services (541519)

PSC

Support Services, Delivered As A Service Contract (Saa S Or Subscription) Involved With The Analysis, Design, Development, Code, Test And Release Packaging Services Associated With Application Development Projects, As Well As Off The Shelf Business Software. (DA10)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 24, 2026
2
Action Date
Feb 27, 2026, 7:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Health and Human Services (HHS), Office of Mission Acquisition Solutions (OMAS), intends to issue a sole-source award to DUN & BRADSTREET INC (D&B) for Business Data Enrichment Services supporting the Food and Drug Administration (FDA). This notice is for an award of perpetual and term licenses, database access, professional verification, and IT integration services. Responses from interested parties are due by February 27, 2026.

Scope of Work

The requirement is for business entity data services, including:

  • Perpetual and term licenses for D&B's proprietary data.
  • Access to D&B's global database of 500+ million company records.
  • Professional verification services, including manual lookups, physical investigations (on-site visits), and global verification with human intelligence.
  • Professional IT services to integrate D&B's COTS solution into FDA systems and maintain ongoing use.

Contract & Timeline

  • Type: Special Notice (Notice of Intent to Limit Sources)
  • Intended Awardee: DUN & BRADSTREET INC (D&B)
  • Justification: D&B is the sole creator/maintainer of the DUNS system, which FDA uses as its statutorily-mandated Unique Facility Identifier (UFI). Switching would disrupt 18 FDA applications. D&B also provides proprietary global data, entity matching, and unique verification services (physical investigations, global human intelligence) that no other vendor can provide at scale.
  • Set-Aside: None (sole-source intent)
  • Response Due: February 27, 2026, 7:00 PM ET
  • Published: February 24, 2026

Evaluation

This is not a request for quotation or solicitation. No quotes will be evaluated. Interested parties may provide information regarding their capabilities. The government's determination not to compete is solely at its discretion.

Additional Notes

Responses should be submitted via email to the Contract Specialist, Renee Jones-Chuang (renee.jones-chuang@hhs.gov).

People

Points of Contact

Renee Jones-ChuangPRIMARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Special Notice
Posted: Feb 24, 2026
Notice of Intent to Limit Sources - Business Data Enrichment Services | GovScope